TrialMovement disorders : official journal of the Movement Disorder Society2020

A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.

Wassilios G Meissner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.